The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "The 4-1BB Pathway: A Deep Dive in Cancer Immunotherapy Targets" is the sixth seminar in the series.Co-chairs:
Faculty:
Seminar agenda:
Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us